Navigation Links
Benefits of higher oxygen, breathing device persist after infancy
Date:12/27/2012

By the time they reached toddlerhood, very preterm infants originally treated with higher oxygen levels continued to show benefits when compared to a group treated with lower oxygen levels, according to a follow-up study by a research network of the National Institutes of Health that confirms earlier network findings. Moreover, infants treated with a respiratory therapy commonly prescribed for adults with obstructive sleep apnea fared as well as those who received the traditional therapy for infant respiratory difficulties, the new study found.

In the original 2010 study, of infants born between 24 to 27 weeks of gestation, investigators in the Neonatal Research Network found:

  • Infants were more likely to survive if they had received higher oxygen levels, although they were at higher risk of an eye condition that can impair vision or lead to blindness.

  • Continuous positive airway pressure (CPAP), a treatment typically reserved for adults with obstructive sleep apnea, was as effective as standard therapy with a ventilator and surfactant (a sticky substance that coats the inside of the lungs).

For the current study, the researchers checked on the children's progress, comparing the groups' survival rates and cognitive and motor development 18 to 22 months after they were originally due to be born. The re-evaluation of the original study treatment groups examined:

  • Children treated with oxygen saturation levels that were either low (85 percent to 89 percent) or high (91 percent to 95 percent).

  • Children treated with CPAP therapy and those treated with a ventilator and surfactant.

The researchers compiled the results of their analysis in terms of a combined primary outcome. This primary outcome took into account two possibilities: whether an infant either died in the first or second year of life or had a neurodevelopmental impairmentany of a number of conditions affecting the nervous system. These included cerebral palsy, blindness, hearing loss or low scores on tests of infant mental and motor development. The researchers selected this outcome because infants who died before 18 months of age could not be classified as having a neurodevelopmental impairment.

In terms of the primary outcome, the researchers found no differences between the groups.

When the researchers looked at outcome measures separately, however, they did observe differences. The researchers documented higher survival rates among children who received oxygen with higher saturation rates. The study's original findings showed that survivors in this group also had a greater risk of developing retinopathy of prematurity, an eye condition that can impair vision or cause blindness. Although those receiving higher oxygen levels were more likely to have had corrective eye surgery, by the time the children reached 18 to 22 months corrected age -- their age had they been born at the approximate time they were due. The researchers found that there was no difference in the rate of vision problems between the two groups.

"CPAP for infants has been available since the 1970s. This is the first study to compare surfactant treatment to CPAP in a large group of infants, and these results reassure us that CPAP is as good a choice in the first hour of life as traditional methods for very preterm babies who need help breathing," said senior author Rosemary D. Higgins, M.D., of the Pregnancy and Perinatology Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), one of two NIH institutes supporting the study. "We've also confirmed that higher oxygen targets improve survival and don't appear to threaten survivors' vision in the longer term."

The study also received funding from the National Heart, Lung and Blood Institute.

Their findings appear in the New England Journal of Medicine.

The research was conducted at hospitals affiliated with the NICHD-funded Neonatal Research Network.

More than 1,300 preterm infants born between 2005 and 2009 were included in the study. Between 18 and 22 months after the infants' original due date, researchers assessed whether the children had cerebral palsy and evaluated their vision, hearing, physical mobility and cognitive development.

The researchers found that 60 percent of the children showed typical physical and cognitive development for their age.

"Although these findings can give delivery room practitioners confidence in a suitable approach, they can't help predict how these children will grow or how well they'll do in school," Dr. Higgins said. "Our group will continue to monitor the health of a subset of these children through childhood, to determine if there are any major differences between the groups."


'/>"/>

Contact: Robert Bock
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development
Source:Eurekalert

Related medicine news :

1. Zane Benefits Posts Information & Videos on Defined Contribution Healthcare
2. Zane Benefits Publishes "The Crisis in Employee Health Benefits 1999-2012"
3. Robotic-assisted radical bladder surgery potentially benefits bladder cancer patients
4. Long-terms benefits follow brain surgery for certain forms of epilepsy
5. Shady Grove Eye and Vision Care Reminds Patients to Book Appointments Now Before 2012 Flex Benefits Run Out
6. Zane Benefits Publishes Information About Large Companies Switching to Defined Contribution & Private Exchanges for Employee Health Benefits
7. Zane Benefits Publishes Section 125 Premium Only Plan (POP) Reimbursable Health Insurance Premiums
8. Kentucky Social Security Disability Benefits Lawyer with The Frank Jenkins Law Office Voices Support for Recent Expansion of Compassionate Allowance Program
9. More signs of the benefits of marriage?
10. Zane Benefits Publishes 5-Step Defined Contribution Evaluation
11. Why Health Insurance Brokers Need An HRA Administration Partner: Zane Benefits Publishes Info
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College ... academic programs. , Answering to the increasing demand for curricular specializations, the Certificate ... and environmental and land use law. ,  , “The demand for lawyers with ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
(Date:5/26/2016)... ... 2016 , ... MadgeTech will be showcasing its line of data logging ... at the MadgeTech headquarters. With products sold in more than 100 countries around the ... NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... WELLESLEY, Massachusetts , May 26, 2016 ... sequencing (NGS) has matured into an essential life science ... research and development applications. BCC Research reveals in its ... of a second growth phase, one powered by a ... applied fields.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ...
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology: